Data / New clinical trials / Hematologic Neoplasms

Hematologic Neoplasms trials: 192 new since Nov 2024

Name: New Hematologic Neoplasms clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Hematologic Neoplasms clinical trials: 192 rows for $9.60, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 9 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/hematologic-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

192 clinical studies in Hematologic Neoplasms were first posted on ClinicalTrials.gov from November 13, 2024 to November 9, 2026; 43 have an industry sponsor and 161 are recruiting or about to. The newest, NCT07926698, was posted on November 9, 2026: Lanoracopan to Prevent Acute GVHD Following Haploidentical Peripheral Blood Stem Cell Transplantation: A... (The First Affiliated Hospital of Soochow University).

The request: Every new Hematologic Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

192New trials
43Industry sponsored
161Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 192, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926698	Lanoracopan to Prevent Acute GVHD Following Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Multicenter Single-Arm...	The First Affiliated Hospital of Soochow University	Phase 2	Not yet recruiting	Hematologic Malignancies, Haploidentical Peripheral Blood Stem Cell Transplantation, Acute Graft-Versus-Host Disease	30		clinicaltrials.gov
November 9, 2026	NCT07926217	High-Dose Versus Standard-Dose Influenza Vaccine in Patients With Hematologic Malignancies Receiving B-Cell-Depleting Therapy	Sung-Han Kim	Phase 2	Recruiting	Hematologic Malignancy, Influenza	60	South Korea	clinicaltrials.gov
November 6, 2026	NCT07923162	MACE and BTK Inhibitors	University Hospital, Caen	Phase 4	Not yet recruiting	Hematologic Cancer, MACE, BTK Inhibitors	10,000	France	clinicaltrials.gov
November 6, 2026	NCT07923071	A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment	Syndax Pharmaceuticals	Phase 1	Not yet recruiting	Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia, Refractory Leukemia, Relapsed Leukemia	18		clinicaltrials.gov
October 28, 2026	NCT07900542	Middle East Study of Infections in Patients With Hematological Malignancies	Hamad Medical Corporation	Observational	Recruiting	Hematological Malignancy, Hematopoetic Stem Cell Transplantation, Bloodstream Infection	1,000	Jordan, Oman, Qatar, Saudi Arabia, United Arab Emirates	clinicaltrials.gov
October 27, 2026	NCT07899632	A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid Tumors	Medsyn Biopharma, LLC	Phase 1/2	Not yet recruiting	Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic, Ovarian Cancer...	75		clinicaltrials.gov
October 26, 2026	NCT07895693	Comprehensive Palliative Care After Stem Cell Transplantation: a Feasability Study	Lisa Hentsch	Not applicable	Recruiting	Hematopoietic Stem Cell Transplantation (HSCT)	42	Switzerland	clinicaltrials.gov
October 26, 2026	NCT07894601	Virtual Reality Intervention to Improve Comfort in Hospitalized Hematology Patients	Fundación para la Investigación del Hospital Clínico de Valencia	Not applicable	Recruiting	Hematologic Cancer	145	Spain	clinicaltrials.gov
October 23, 2026	NCT07891533	Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera	AN2 Therapeutics, Inc	Phase 2	Not yet recruiting	Polycythemia Vera (SNOMED CT: 109992005)	75	Australia	clinicaltrials.gov
October 21, 2026	NCT07886190	Symptom Monitoring and Management Intervention After CAR-T	Massachusetts General Hospital	Not applicable	Not yet recruiting	Chimeric Antigen Receptor T-cell Therapy, Hematologic Malignancy	65	United States	clinicaltrials.gov
October 14, 2026	NCT07873827	KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme Malignancies	Stemline Therapeutics, Inc.	Phase 1/2	Not yet recruiting	Hematological Malignancy	115		clinicaltrials.gov
October 14, 2026	NCT07872813	Effects of Resistance Training on Recovery During Hematopoietic Stem Cell Transplantation	Taipei Veterans General Hospital, Taiwan	Not applicable	Not yet recruiting	Hematologic Malignancies, Hematopoietic Stem Cell Transplantation, Resistance Training, Neutropenia, Acute...	86	Taiwan	clinicaltrials.gov
October 7, 2026	NCT07864467	BHF-COLLATE: UK Prospective, Multi-centre, Observational, Cardio-oncology Anthracycline Registry	South Tees Hospitals NHS Foundation Trust	Observational	Not yet recruiting	Cancer and / or Hematological Malignancy, Anthracycline-induced Cardiotoxicity	200	United Kingdom	clinicaltrials.gov
October 6, 2026	NCT07861971	Feasibility Study of a Sports-Inspired Onco-Coaching Progranm for Young Adults i Cancer Remission	Institut Paoli-Calmettes	Observational	Recruiting	Solid and Hematologic Cancer	19	France	clinicaltrials.gov
October 6, 2026	NCT07861620	Animal-Assisted Intervention for Children With Cancer and Their Siblings	Azienda Ulss 2 Marca Trevigiana	Not applicable	Completed	Hematologic Neoplasms, Neoplasms	50	Italy	clinicaltrials.gov
October 6, 2026	NCT07861477	Murottal as Adjunctive Intervention in Pediatric	Universitas Airlangga	Not applicable	Completed	Pediatric Cancer, Hematologic Malignancies, Anxiety, Sleep Disturbances in Children, Leukemia (Both ALL and AML)	20	Indonesia	clinicaltrials.gov
September 29, 2026	NCT07845669	Effects of Synbiotic Supplementation on Gastrointestinal Symptoms, Appetite, and Nutritional Recovery in Patients After Autologous Bone...	Alexandria University	Not applicable	Not yet recruiting	Hematologic Neoplasms, Gastrointestinal Symptoms, Malnutrition, Loss of Appetite, Anorexia, Dysbiosis	40	Egypt	clinicaltrials.gov
September 25, 2026	NCT07842679	Cognitive Impairment in Older Adults With Hematologic Malignancies	Assiut University	Observational	Not yet recruiting	Cognitive Impairment, Hematologic Malignancies, Chemotherapy Effect	120		clinicaltrials.gov
September 17, 2026	NCT07825714	Metagenomic Sequencing Across the Infectious Disease Risk and Care Continuum	Karius, Inc.	Observational	Not yet recruiting	Infectious Diseases, Immunocompromised Host, Opportunistic Infections	10,000		clinicaltrials.gov
September 10, 2026	NCT07814170	A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece	University of West Attica	Not applicable	Active not recruiting	Blood Cancers, Leukemia, Lymphoma, Bone Marrow Transplant, Psychological Trauma, Neoplasms, Hematological Malignancies...	80	Greece	clinicaltrials.gov
September 9, 2026	NCT07809906	Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression	Orum Therapeutics USA, Inc.	Phase 1	Recruiting	CD123+ Acute Myeloid Leukemia	42	United States	clinicaltrials.gov
September 9, 2026	NCT07809139	A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic Malignancies	Nanjing Miracle Biotechnology Co., Ltd.	Phase 1	Not yet recruiting	Hematological Malignancies	30	China	clinicaltrials.gov
September 9, 2026	NCT07809126	A Phase I, Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Injection in...	Nanjing Miracle Biotechnology Co., Ltd.	Phase 1	Not yet recruiting	Hematological Malignancies	30	China	clinicaltrials.gov
September 8, 2026	NCT07808112	CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell...	Medical College of Wisconsin	Phase 2	Not yet recruiting	Graft -Versus-host-disease	72	United States	clinicaltrials.gov
September 3, 2026	NCT07802756	Dose-Escalation/Expansion Study of iMagic in Relapsed/Refractory Hematologic Malignancies	Suzhou Immunofoco Biotechnology Co., Ltd	Early phase 1	Not yet recruiting	Relapsed/Refractory Hematologic Malignancies	30	China	clinicaltrials.gov
September 3, 2026	NCT07802015	Home-based Intravenous Cytarabine Treatment for Acute Myeloid Leukemia: a National Danish Study of Feasibility, Costs, and Implementation	Zealand University Hospital	Observational	Not yet recruiting	Hematologic Cancer, Acute Myeloid Leukaemia (AML), Hospital At Home, Home-based Chemotherapy	80		clinicaltrials.gov
August 25, 2026	NCT07785505	Musculoskeletal Ultrasound in Patients With Hematologic Malignancies	Assiut University	Observational	Not yet recruiting	Hematologic Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal Diseases	50		clinicaltrials.gov
August 13, 2026	NCT07763184	mNGS for IFD in Patients With Hematological Malignancies	Nanfang Hospital, Southern Medical University	Observational	Not yet recruiting	Hematological Malignancies, Invasive Fungal Disease	50	China	clinicaltrials.gov
August 13, 2026	NCT07763054	Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients	Haikou Affiliated Hospital of Central South University Xiangya School of Medicine	Observational	Recruiting	Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic...	30	China	clinicaltrials.gov
August 10, 2026	NCT07756034	Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer	Tempus AI	Observational	Recruiting	Cancer, Solid Tumor Cancer, Pediatric Acute Myeloid Leukemia, Hematologic Malignancies	1,000	United States	clinicaltrials.gov
August 7, 2026	NCT07753148	Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic...	Regeneron Pharmaceuticals	Phase 1	Recruiting	Clonal Cytopenia of Undetermined Significance (CCUS), Low-Risk Myelodysplastic Syndrome (LR-MDS)	52	Belgium	clinicaltrials.gov
August 4, 2026	NCT07743476	Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions	M.D. Anderson Cancer Center	Observational	Recruiting	Hematologic, Oncologic, Bone Marrow	1,000	United States	clinicaltrials.gov
July 24, 2026	NCT07724873	Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients	Tata Memorial Centre	Phase 1/2	Recruiting	Hematopoietic Stem Cell Transplant (HSCT), GVHD - Graft-Versus-Host Disease, Hematological Malignancy	54	India	clinicaltrials.gov
July 22, 2026	NCT07719946	To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers	Tata Memorial Centre	Phase 2	Recruiting	Haploidentical Hematopoietic Stem Cell Transplant, Hematological Malignancies	20	India	clinicaltrials.gov
July 20, 2026	NCT07714044	Rutgers University Study of the Genetics of Blood Cancers	Rutgers, The State University of New Jersey	Observational	Recruiting	Blood Cancers, Blood Cancer, Leukemia, Lymphoma, Myeloma, Hematologic Cancer, Hematologic Malignancies, Hematologic...	10,000	United States	clinicaltrials.gov
July 20, 2026	NCT07712835	ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis	Children's Mercy Hospital Kansas City	Observational	Completed	ECMO Outcomes, Respiratory Failure (Pediatric Patients), Malignancies, Hematologic, Solid Tumor Malignancies...	22		clinicaltrials.gov
July 17, 2026	NCT07711327	Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy	Tina Baykaner	Observational	Not yet recruiting	Atrial Fibrillation (AF), Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Marginal...	500	United States	clinicaltrials.gov
July 17, 2026	NCT07710781	Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic...	Ossium Health, Inc.	Not applicable	Not yet recruiting	Hematologic Malignancy, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic...	300		clinicaltrials.gov
July 16, 2026	NCT07709637	Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients	LucasBio	Phase 1	Active not recruiting	COVID-19, COVID-19 (SARS-CoV-2 Infection)	1	South Korea	clinicaltrials.gov
July 16, 2026	NCT07709195	Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant	Tata Memorial Centre	Phase 2	Recruiting	Oral Mucositis, Total Body Irradiation, Hematological Malignancies, Hematopoietic Stem Cell Transplantation (HSCT)	17	India	clinicaltrials.gov
July 16, 2026	NCT07709013	Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients	Tata Memorial Centre	Phase 2	Recruiting	Hematologic Malignancies	22	India	clinicaltrials.gov
July 16, 2026	NCT07709000	A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)	Merck Sharp & Dohme LLC	Phase 2	Recruiting	Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Hematologic Malignancies	60	Colombia, Israel	clinicaltrials.gov
July 16, 2026	NCT07708987	Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.	Tata Memorial Centre	Phase 2	Recruiting	Hematological Malignancy, GVHD - Graft-Versus-Host Disease, Steriod Refractory	34	India	clinicaltrials.gov
July 14, 2026	NCT07703644	Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients	Sizhou Feng	Observational	Not yet recruiting	Hematologic Neoplasms, Gram-Negative Bacterial Infections, Pseudomonas Aeruginosa Infection, Klebsiella Pneumoniae...	60	China	clinicaltrials.gov
July 8, 2026	NCT07691008	Wearable Data for Personalized Prognostication in Cancer: A Registry Protocol	City of Hope Medical Center	Observational	Not yet recruiting	Hematopoietic Neoplasm, Malignant Solid Neoplasm, Lymphatic System Neoplasm, Hematopoietic and Lymphatic System Neoplasm	1,200		clinicaltrials.gov
July 8, 2026	NCT07689630	Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 3	Recruiting	Graft Versus Host Disease, Hematologic Neoplasms	186	China	clinicaltrials.gov
July 1, 2026	NCT07679412	Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.	LucasBio	Not applicable	Recruiting	CMV Retinitis	5	South Korea	clinicaltrials.gov
July 1, 2026	NCT07678307	A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of...	Institute of Hematology & Blood Diseases Hospital, China	Phase 1/2	Not yet recruiting	T-Cell Acute Lymphoblastic Leukemia, T-Lymphoblastic Lymphoma, Relapsed/Refractory Hematologic Malignancies	18		clinicaltrials.gov
June 29, 2026	NCT07674212	Take5Care+: A Self-management Educational Intervention	Jitka Vseteckova	Not applicable	Not yet recruiting	Hematologic Neoplasms	20		clinicaltrials.gov
June 29, 2026	NCT07672964	CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical Transplantation	Ruijin Hospital	Phase 1	Not yet recruiting	Hematologic Malignancy, Haplo-identical HCT	30	China	clinicaltrials.gov
June 23, 2026	NCT07662382	Cousin vs. Sibling Donors in Haplo-HSCT	The First Affiliated Hospital of Soochow University	Observational	Not yet recruiting	Hematopoietic Malignancies, Haploidentical Hematopoietic Stem Cell Transplantation, Donor	1,000	China	clinicaltrials.gov
June 23, 2026	NCT07662369	CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation	Ruijin Hospital	Phase 1/2	Recruiting	Hematologic Malignancy, Haplo-identical HCT	30	China	clinicaltrials.gov
June 17, 2026	NCT07653672	Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With...	Centre Hospitalier Annecy Genevois	Observational	Recruiting	Thrombocytopenia, Platelet Transfusion, Haemorrhage, Hematologic Malignancies	410	France	clinicaltrials.gov
June 15, 2026	NCT07648264	Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting...	CSL Behring	Phase 3	Recruiting	Secondary Immune Deficiency	63	Belgium, Canada, Czechia, Denmark, France, Germany, Italy, Poland, Spain...	clinicaltrials.gov
June 9, 2026	NCT07636486	Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies	Nanfang Hospital, Southern Medical University	Phase 2/3	Not yet recruiting	Luspatercept, Epoetin, Poor Erythroid Engraftment, Hematological Malignancies	90	China	clinicaltrials.gov
June 9, 2026	NCT07635511	Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies	The First Affiliated Hospital of Soochow University	Phase 3	Not yet recruiting	Hematological Malignancies, Platelet Transfusion Refractoriness (PTR), HLA Antibodies	42		clinicaltrials.gov
June 8, 2026	NCT07634263	Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study	Odense University Hospital	Observational	Not yet recruiting	Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma Progression, Multiple...	50	Denmark	clinicaltrials.gov
June 5, 2026	NCT07629726	A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms	Kyowa Kirin Co., Ltd.	Phase 1/2	Recruiting	Hematologic Neoplasms	72	United States	clinicaltrials.gov
June 2, 2026	NCT07621887	Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer	The Hong Kong Polytechnic University	Not applicable	Not yet recruiting	Hematologic Cancer, Leukaemia, Lymphoma, Physical Activity	30		clinicaltrials.gov
June 2, 2026	NCT07621289	Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe	University Hospital, Caen	Observational	Not yet recruiting	Cancer, Anticancer Treatment, Cardiovascular Disease Risk Factor, Cardiovascular Diseases, Hematological Malignancies	10,000		clinicaltrials.gov
May 27, 2026	NCT07609485	Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy	University Hospital, Lille	Observational	Recruiting	Cancer, Hematologic Malignancy	700	France	clinicaltrials.gov
May 26, 2026	NCT07607379	Robotic Dog Intervention on Emotional Well-Being and Quality of Life	Koç University	Not applicable	Not yet recruiting	Emotional Well-being, Quality of Life, Pediatric Oncology	28		clinicaltrials.gov
May 15, 2026	NCT07590648	Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia	Hospital Universitari Vall d'Hebron Research Institute	Phase 4	Not yet recruiting	Febrile Neutropenia (FN), Pediatric Cancer, Hematologic Malignancies, Solid Tumors, Invasive Bacterial Infection	136	Spain	clinicaltrials.gov
May 11, 2026	NCT07579065	HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT	Azienda USL Reggio Emilia - IRCCS	Not applicable	Recruiting	Hematologic Neoplasm, Hematopoietic Stem Cell Transplantation, Survivorship, Cancer Survivorship	40	Italy	clinicaltrials.gov
May 7, 2026	NCT07572006	A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies	Janssen Research & Development, LLC	Phase 1	Recruiting	Hematologic Neoplasms	320	Australia, Belgium, Denmark, France, Spain, United Kingdom, United States	clinicaltrials.gov
May 6, 2026	NCT07570563	Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.	Chinese PLA General Hospital	Phase 1/2	Recruiting	Hematologic Malignancy, Solid Tumor	24	China	clinicaltrials.gov
April 21, 2026	NCT07541326	Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France	University Hospital, Limoges	Not applicable	Not yet recruiting	Hematological Malignancies	85	France	clinicaltrials.gov
April 20, 2026	NCT07539779	Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis	Nanfang Hospital, Southern Medical University	Phase 2/3	Not yet recruiting	Luspatercept, Poor Erythroid Engraftment, Hematological Malignancies, Myelofibrosis (MF)	196	China	clinicaltrials.gov
April 16, 2026	NCT07532746	A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies	Kousai Bio Co., Ltd.	Phase 1	Not yet recruiting	Relapsed or Refractory EBV-associated Hematological Malignancies	55	China	clinicaltrials.gov
April 13, 2026	NCT07524530	Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers	National Cancer Institute (NCI)	Phase 2	Not yet recruiting	Core Binding Factor Alpha Subunits, Hematologic Neoplasms, Leukemia, Lymphoma	102	United States	clinicaltrials.gov
April 13, 2026	NCT07523555	Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies	Beijing Biotech	Phase 1/2	Recruiting	Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL...	96	China	clinicaltrials.gov
April 9, 2026	NCT07519811	LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)	Technical University of Munich	Not applicable	Recruiting	Hematologic Neoplasms, Oncologic Disorders	150	Germany	clinicaltrials.gov
April 6, 2026	NCT07511127	Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT	Ruijin Hospital	Phase 3	Recruiting	Hematologic Malignancy	218	China	clinicaltrials.gov
March 31, 2026	NCT07504458	Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia	Quetzal Therapeutics	Phase 3	Recruiting	Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute...	150	France, Italy, Romania, Spain, United States	clinicaltrials.gov
March 20, 2026	NCT07485855	Influenza Vaccination Strategy for Patients With Hematologic Malignancy	Asan Medical Center	Phase 3	Recruiting	Hematologic Neoplasms, Influenza, Immunogenicity	120	South Korea	clinicaltrials.gov
March 20, 2026	NCT07485504	Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies	Tcelltech Inc.	Phase 1	Not yet recruiting	Relapsed or Refractory Hematologic Malignancies	15	China	clinicaltrials.gov
March 16, 2026	NCT07474051	Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials	AvenCell Therapeutics, Inc.	Observational	Enrolling by invitation	B-cell Lymphoma, Chronic Lymphocytic Leukemia, Hematologic Malignancy, AML (Acute Myelogenous Leukemia), Prostate Cancer	178	Germany	clinicaltrials.gov
March 11, 2026	NCT07463976	variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway	The Royal Wolverhampton Hospitals NHS Trust	Observational	Not yet recruiting	Chronic Lymphocytic Leukemia, Haematological Malignancy	130	United Kingdom	clinicaltrials.gov
March 10, 2026	NCT07462962	Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During...	Henan University	Observational	Completed	Hematopoietic Stem Cell Transplantation (HSCT), Cancer and / or Hematological Malignancy	70	China	clinicaltrials.gov
March 9, 2026	NCT07456982	The Effect of Relaxation Breathing Exercise on Chemotherapy Induced Nausea and Vomiting	Marmara University	Not applicable	Active not recruiting	Nausea and Vomiting Chemotherapy-Induced, Hematological Malignancies	68	Turkey (Türkiye)	clinicaltrials.gov
March 6, 2026	NCT07456189	The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of...	Institute of Hematology & Blood Diseases Hospital, China	Not applicable	Not yet recruiting	HSCT, Hematologic Cancer	20		clinicaltrials.gov
March 2, 2026	NCT07441967	The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single...	Institute of Hematology & Blood Diseases Hospital, China	Phase 2	Not yet recruiting	Hematologic Malignancies	44		clinicaltrials.gov
February 27, 2026	NCT07440290	DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF...	Cancer Research UK	Phase 2/3	Recruiting	Haematological Malignancy, Malignant Neoplasm, Lymphoproliferative Disorders, Neoplasms by Histologic Type, Neoplasms...	30	United Kingdom	clinicaltrials.gov
February 20, 2026	NCT07424833	A Study of APG-3288 in Relapsed/Refractory Blood Cancers	Ascentage Pharma Group Inc.	Phase 1	Recruiting	Relapsed/Refractory Hematological Malignancies, Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic...	180	China, United States	clinicaltrials.gov
February 17, 2026	NCT07413991	Expressive Writing Program Among Young Adults With Blood Cancer	Blood Cancer United	Not applicable	Active not recruiting	Hematologic Malignancy	100	United States	clinicaltrials.gov
February 13, 2026	NCT07409662	Coverage and Cost of Care Links- Telehealth	Jean Edward	Not applicable	Completed	Financial Stress, Hematologic Cancer, Survivorship	124	United States	clinicaltrials.gov
February 11, 2026	NCT07403812	Assessing DCog Short for Neurotoxicity in CAR-T	Beth Israel Deaconess Medical Center	Not applicable	Recruiting	Neurotoxicity, Neurotoxicity Syndromes, Hematologic Malignancy, Immune Effector Cell Associated Neurotoxicity Syndrome	40	United States	clinicaltrials.gov
January 26, 2026	NCT07367997	Comparative Effectiveness of Verbal Instruction Versus Simulation Video Education Among Cancer Patients Undergoing Radiation Therapy	Jinnah Postgraduate Medical Centre	Not applicable	Completed	Cancer (Solid Tumors), Cancer and / or Hematological Malignancy	100	Pakistan	clinicaltrials.gov
January 23, 2026	NCT07362732	Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection	Sichuan University	Early phase 1	Not yet recruiting	Hematological Malignancies	20		clinicaltrials.gov
January 23, 2026	NCT07362602	Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies	The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army	Early phase 1	Not yet recruiting	Hematological Malignancies	47		clinicaltrials.gov
January 23, 2026	NCT07362225	MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative...	MPN Research Foundation	Observational	Recruiting	Polycythemia Vera, ET (Essential Thrombocythemia), Polycythemia Vera (PV), Essential Thrombocythemia (ET), Primary...	5,000	United States	clinicaltrials.gov
January 22, 2026	NCT07359859	A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell...	Memorial Sloan Kettering Cancer Center	Phase 2	Recruiting	Hematologic Malignancies	40	United States	clinicaltrials.gov
January 22, 2026	NCT07358195	Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation	Massachusetts General Hospital	Early phase 1	Recruiting	Kidney Failure Chronic, Stem Cell Transplant, Stem Cell Transplant Complications, Tolerance, Hematologic Cancer	3	United States	clinicaltrials.gov
January 16, 2026	NCT07346105	Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies	Orca Biosystems, Inc.	Not applicable	Available	Hematologic Malignancies, Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myelodysplastic Syndrome, Mixed Phenotype...	Not listed	United States	clinicaltrials.gov
January 5, 2026	NCT07316907	A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies	YANRU WANG	Phase 1	Not yet recruiting	Hematologic Malignancies, Lymphoma	12	China	clinicaltrials.gov
December 26, 2025	NCT07305090	Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease...	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Observational	Recruiting	Blood Cancer	90	Italy	clinicaltrials.gov
December 24, 2025	NCT07300735	Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers	Alexandria University	Not applicable	Recruiting	Hematologic Malignancy, Neutropenia, Bone Pain	88	Egypt	clinicaltrials.gov
December 22, 2025	NCT07297160	CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors	Baylor College of Medicine	Phase 1	Withdrawn	Lymphoma, Myeloma, Solid Tumors, Sarcoma, Kidney Cancer	0	United States	clinicaltrials.gov
December 19, 2025	NCT07294300	A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies	Qilu Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	Relapsed/Refractory Hematological Malignancies	124	China	clinicaltrials.gov
December 18, 2025	NCT07292272	Halt Aging in Survivors of Blood Cancers	University of Nebraska	Not applicable	Recruiting	Hematological Malignancy, Leukemia, Lymphoid Leukemia, Multiple Myeloma, Myeloid Leukemia, Monocytic Leukemia...	180	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Institute of Hematology & Blood Diseases Hospital, China	6	July 1, 2026
Tata Memorial Centre	5	July 24, 2026
Ruijin Hospital	4	June 29, 2026
National Cancer Institute (NCI)	4	April 13, 2026
The First Affiliated Hospital of Soochow University	3	November 9, 2026
Massachusetts General Hospital	3	October 21, 2026
Assiut University	3	September 25, 2026
Nanfang Hospital, Southern Medical University	3	August 13, 2026
M.D. Anderson Cancer Center	3	August 4, 2026
Memorial Sloan Kettering Cancer Center	3	January 22, 2026
IRCCS Azienda Ospedaliero-Universitaria di Bologna	3	December 26, 2025
Wake Forest University Health Sciences	3	October 2, 2025
University Hospital, Caen	2	November 6, 2026
Alexandria University	2	September 29, 2026
Nanjing Miracle Biotechnology Co., Ltd.	2	September 9, 2026
Tempus AI	2	August 10, 2026
LucasBio	2	July 16, 2026
City of Hope Medical Center	2	July 8, 2026
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	2	July 8, 2026
Azienda USL Reggio Emilia - IRCCS	2	May 11, 2026

By phase

Phase	New trials	Latest
Not applicable	57	October 26, 2026
Observational	47	October 28, 2026
Phase 1	29	November 6, 2026
Phase 2	20	November 9, 2026
Phase 1/2	15	October 27, 2026
Early phase 1	9	September 3, 2026
Phase 3	8	July 8, 2026
Phase 2/3	4	June 9, 2026
Phase 4	3	November 6, 2026

By country

Country	New trials	Latest
United States	65	October 21, 2026
China	42	September 9, 2026
France	16	November 6, 2026
Italy	13	October 6, 2026
Spain	12	October 26, 2026
United Kingdom	9	October 7, 2026
South Korea	5	November 9, 2026
Australia	5	October 23, 2026
Belgium	5	August 7, 2026
India	5	July 24, 2026
Denmark	5	June 15, 2026
Germany	5	June 15, 2026
Canada	4	June 15, 2026
Egypt	3	September 29, 2026
Czechia	3	June 15, 2026
Poland	3	June 15, 2026
Turkey (Türkiye)	3	March 9, 2026
Switzerland	2	October 26, 2026
Taiwan	2	October 14, 2026
Greece	2	September 10, 2026
Japan	2	October 24, 2025
Hungary	2	September 15, 2025
Jordan	1	October 28, 2026
Oman	1	October 28, 2026
Qatar	1	October 28, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.